Literature DB >> 21245496

Natural killer cells mediate severe liver injury in a murine model of halothane hepatitis.

Christine M Dugan1, Aaron M Fullerton, Robert A Roth, Patricia E Ganey.   

Abstract

Severe halothane (HAL)-induced hepatotoxicity occurs in one in 6000-30,000 patients by an unknown mechanism. Female sex is a risk factor in humans and rodents. We tested the hypothesis that a sex difference in natural killer (NK) cell activity contributes to HAL-induced liver injury. HAL (15 mmol/kg, ip) treatment resulted in severe liver injury by 12 h in female, wild-type BALB/cJ mice, and the magnitude of liver injury varied with stage of the estrous cycle. Ovariectomized (OVX) mice developed only mild liver injury. Plasma interferon-gamma (IFN-γ) was elevated 10-fold in HAL-treated females compared with similarly treated male mice or with OVX female mice. IFN-γ knockout mice were resistant to severe HAL-induced liver injury. The deactivation of NK cells with anti-asialo GM1 treatment attenuated liver injury and the increase in plasma IFN-γ compared with immunoglobulin G-treated control mice. Mice with a mutated form of perforin, a protein involved in granule-mediated cytotoxicity, were protected from severe liver injury. Furthermore, HAL increased the activity of NK cells in vivo, as indicated by increased surface expression of CD69, an early activation marker. In response to HAL, NK cell receptor ligands on the surface of hepatocytes were expressed in a manner that can activate NK cells. These results confirm the sexual dimorphic hepatotoxic response to HAL in mice and suggest that IFN-γ and NK cells have essential roles in the development of severe HAL-induced hepatotoxicity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21245496      PMCID: PMC3061480          DOI: 10.1093/toxsci/kfr005

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  54 in total

Review 1.  The CTL's kiss of death.

Authors:  G Berke
Journal:  Cell       Date:  1995-04-07       Impact factor: 41.582

Review 2.  Epidemiology of hepatocellular carcinoma.

Authors:  F Xavier Bosch; Josepa Ribes; Ramon Cléries; Mireia Díaz
Journal:  Clin Liver Dis       Date:  2005-05       Impact factor: 6.126

3.  Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes.

Authors:  Y Tagawa; K Sekikawa; Y Iwakura
Journal:  J Immunol       Date:  1997-08-01       Impact factor: 5.422

Review 4.  Role of innate immunity in acetaminophen-induced hepatotoxicity.

Authors:  Zhang-Xu Liu; Neil Kaplowitz
Journal:  Expert Opin Drug Metab Toxicol       Date:  2006-08       Impact factor: 4.481

Review 5.  Cytokines, STATs and liver disease.

Authors:  Bin Gao
Journal:  Cell Mol Immunol       Date:  2005-04       Impact factor: 11.530

6.  Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver.

Authors:  T Toyonaga; O Hino; S Sugai; S Wakasugi; K Abe; M Shichiri; K Yamamura
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

Review 7.  The molecular cell biology of interferon-gamma and its receptor.

Authors:  M A Farrar; R D Schreiber
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

8.  Halothane-induced liver injury in guinea-pigs: importance of cytochrome P450 enzyme activity and hepatic blood flow.

Authors:  G C Farrell; L Frost; M Tapner; J Field; M Weltman; J Mahoney
Journal:  J Gastroenterol Hepatol       Date:  1996-06       Impact factor: 4.029

9.  Sex differences in the prolongation of allogeneic skin graft survival in rats treated with cyclosporin A: effects of orchiectomy and pregnancy.

Authors:  K Hirasawa; S Enosawa
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

10.  Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.

Authors:  F P Heinzel; M D Sadick; B J Holaday; R L Coffman; R M Locksley
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

View more
  9 in total

1.  Eosinophils mediate the pathogenesis of halothane-induced liver injury in mice.

Authors:  William R Proctor; Mala Chakraborty; Lynette S Chea; Jeffrey C Morrison; Julia D Berkson; Kenrick Semple; Mohammed Bourdi; Lance R Pohl
Journal:  Hepatology       Date:  2013-03-15       Impact factor: 17.425

2.  Synergistic Cytotoxicity from Drugs and Cytokines In Vitro as an Approach to Classify Drugs According to Their Potential to Cause Idiosyncratic Hepatotoxicity: A Proof-of-Concept Study.

Authors:  Ashley R Maiuri; Bronlyn Wassink; Jonathan D Turkus; Anna B Breier; Theresa Lansdell; Gurpreet Kaur; Sarah L Hession; Patricia E Ganey; Robert A Roth
Journal:  J Pharmacol Exp Ther       Date:  2017-07-07       Impact factor: 4.030

3.  Cytotoxic Synergy Between Cytokines and NSAIDs Associated With Idiosyncratic Hepatotoxicity Is Driven by Mitogen-Activated Protein Kinases.

Authors:  Ashley R Maiuri; Anna B Breier; Lukas F J Gora; Robert V Parkins; Patricia E Ganey; Robert A Roth
Journal:  Toxicol Sci       Date:  2015-05-07       Impact factor: 4.849

4.  Thymic stromal lymphopoietin and interleukin-4 mediate the pathogenesis of halothane-induced liver injury in mice.

Authors:  William R Proctor; Mala Chakraborty; Aaron M Fullerton; Midhun C Korrapati; Pauline M Ryan; Kenrick Semple; Jeffrey C Morrison; Julia D Berkson; Lynette S Chea; Qian Yang; Albert P Li; Rosanne Spolski; Erin E West; Yrina Rochman; Warren J Leonard; Mohammed Bourdi; Lance R Pohl
Journal:  Hepatology       Date:  2014-05-20       Impact factor: 17.425

5.  Calcium Contributes to the Cytotoxic Interaction Between Diclofenac and Cytokines.

Authors:  Ashley R Maiuri; Anna B Breier; Jonathan D Turkus; Patricia E Ganey; Robert A Roth
Journal:  Toxicol Sci       Date:  2015-11-24       Impact factor: 4.849

Review 6.  Immune Modulation by Volatile Anesthetics.

Authors:  Lindsay M Stollings; Li-Jie Jia; Pei Tang; Huanyu Dou; Binfeng Lu; Yan Xu
Journal:  Anesthesiology       Date:  2016-08       Impact factor: 7.892

7.  Pretreatment with TCDD exacerbates liver injury from Concanavalin A: critical role for NK cells.

Authors:  Aaron M Fullerton; Robert A Roth; Patricia E Ganey
Journal:  Toxicol Sci       Date:  2013-08-22       Impact factor: 4.849

Review 8.  What have we learned from animal models of idiosyncratic, drug-induced liver injury?

Authors:  Robert A Roth; Patricia E Ganey
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-05-04       Impact factor: 4.481

9.  Inhibition of SUMO2/3 antagonizes isoflurane-induced cancer-promoting effect in hepatocellular carcinoma Hep3B cells.

Authors:  Peng Wang; Na Xue; Chunyan Zhang; Shimin Shan; Zhongmin Jiang; Wenhan Wu; Xiaozhi Liu
Journal:  Oncol Lett       Date:  2021-02-10       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.